Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide Robert E. J. Ryder , Katharina Laubner , Marek Benes , Martin Haluzik , Lynne Munro , Harry Frydenberg , Julian P. Teare , Aruchuna Ruban , Sigal Fishman , Erwin Santo , Rainer Stengel , Charlotte De Jonge , Jan W. Greve , Ricardo V. Cohen , Cristina M. Aboud , Gerald J. Holtmann , Graeme Rich , Jess J. McMaster , Tadej Battelino , Primoz Kotnik , James P. Byrne , John C. Mason , Justin Bessell , Jeanine Bascomb , Lillian Kow , Janes Collins , Jacob Chisholm , Peter N. Pferschy , Harald Sourij , Melissa L. Cull , Melanie C. Wyres , Russell Drummond , Barbara McGowan , Stephanie A. Amiel , Mahi Yadagiri , Piya Sen Gupta , Jens Aberle , Jochen Seufert Diabetes Care（2023）
Key words
obesity, diabetes, glycemic, duodenal-jejunal
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
